A program to lead cancer treatment efforts at Dana-Farber Cancer Institute
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
This study at Dana-Farber Cancer Institute is all about finding new and better treatments for cancer, and it invites patients to join in on exciting clinical trials that could help them and others facing different types of cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11251673 on NIH RePORTER |
What this research studies
This program at Dana-Farber Cancer Institute focuses on reducing the burden of cancer by leading efforts in clinical trials and research. It involves a collaboration of top cancer researchers and clinicians who work together to design and implement innovative cancer treatments. Patients may have the opportunity to participate in cutting-edge clinical trials that address various types of cancer, including both common and rare forms. The program aims to enhance patient accrual to these trials, ensuring that more individuals can access potentially life-saving therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with various types of cancer who are seeking innovative treatment options.
Not a fit: Patients with non-cancerous conditions or those who are not eligible for clinical trials may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with access to advanced cancer treatments and improve overall cancer care.
How similar studies have performed: Previous research has shown success in similar collaborative approaches to cancer treatment, indicating a strong potential for impactful outcomes.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Burstein, Harold John — Dana-Farber Cancer Inst
- Study coordinator: Burstein, Harold John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.